Verapamil in a new model of severe local myocardial ischaemia due to combined coronary occlusion and stenosis

A. Végh, L. Szekeres, Éva Udvary

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effect of verapamil was studied in a new canine model of local myocardial ischaemia. In this model in addition to the critical constriction of the left circumflex coronary artery, the left anterior descending branch was suddenly occluded. Experiments were performed in the anaesthetized, thoracotomized and artificially respired dog. The model represents a severe form of myocardial ischaemia and mimics the clinical situation in which usually more than one coronary artery is involved in the stenotic process. Verapamil (0.15 mg kg -1 i.v.) moderated the extent of the ischaemic changes (indicated by the ST segment elevation in the epicardial and endocardial ECG) as well as their consequences e.g. the incidence and severity of early postocclusion and reperfusion arrhythmias. This beneficial effect was probably due to the drug-induced favourable haemodynamic action (reduction of left ventricular end-diastolic pressure and slight increase in left ventricular dP/dtmax) and to the electrophysiological effects (e.g. decreased inhomogeneity of electrical activation, diminution of extrasystolic activity) and blood flow changes (enhanced blood supply to the ischaemic subepicardium).

Original languageEnglish
Pages (from-to)15-27
Number of pages13
JournalEuropean Journal of Pharmacology
Volume144
Issue number1
DOIs
Publication statusPublished - Nov 24 1987

Fingerprint

Coronary Stenosis
Coronary Occlusion
Verapamil
Myocardial Ischemia
Coronary Vessels
Constriction
Reperfusion
Canidae
Cardiac Arrhythmias
Electrocardiography
Hemodynamics
Dogs
Blood Pressure
Incidence
Pharmaceutical Preparations

Keywords

  • Arrhythmias
  • Left anterior descending coronary artery occlusion
  • Left circumflex coronary artery constriction
  • Myocardial ischaemia
  • Regional myocardial blood flow
  • Verapamil

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Verapamil in a new model of severe local myocardial ischaemia due to combined coronary occlusion and stenosis. / Végh, A.; Szekeres, L.; Udvary, Éva.

In: European Journal of Pharmacology, Vol. 144, No. 1, 24.11.1987, p. 15-27.

Research output: Contribution to journalArticle

@article{1c4bef8d1c7d46a7abe3d5b0dbf42310,
title = "Verapamil in a new model of severe local myocardial ischaemia due to combined coronary occlusion and stenosis",
abstract = "The effect of verapamil was studied in a new canine model of local myocardial ischaemia. In this model in addition to the critical constriction of the left circumflex coronary artery, the left anterior descending branch was suddenly occluded. Experiments were performed in the anaesthetized, thoracotomized and artificially respired dog. The model represents a severe form of myocardial ischaemia and mimics the clinical situation in which usually more than one coronary artery is involved in the stenotic process. Verapamil (0.15 mg kg -1 i.v.) moderated the extent of the ischaemic changes (indicated by the ST segment elevation in the epicardial and endocardial ECG) as well as their consequences e.g. the incidence and severity of early postocclusion and reperfusion arrhythmias. This beneficial effect was probably due to the drug-induced favourable haemodynamic action (reduction of left ventricular end-diastolic pressure and slight increase in left ventricular dP/dtmax) and to the electrophysiological effects (e.g. decreased inhomogeneity of electrical activation, diminution of extrasystolic activity) and blood flow changes (enhanced blood supply to the ischaemic subepicardium).",
keywords = "Arrhythmias, Left anterior descending coronary artery occlusion, Left circumflex coronary artery constriction, Myocardial ischaemia, Regional myocardial blood flow, Verapamil",
author = "A. V{\'e}gh and L. Szekeres and {\'E}va Udvary",
year = "1987",
month = "11",
day = "24",
doi = "10.1016/0014-2999(87)90004-5",
language = "English",
volume = "144",
pages = "15--27",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Verapamil in a new model of severe local myocardial ischaemia due to combined coronary occlusion and stenosis

AU - Végh, A.

AU - Szekeres, L.

AU - Udvary, Éva

PY - 1987/11/24

Y1 - 1987/11/24

N2 - The effect of verapamil was studied in a new canine model of local myocardial ischaemia. In this model in addition to the critical constriction of the left circumflex coronary artery, the left anterior descending branch was suddenly occluded. Experiments were performed in the anaesthetized, thoracotomized and artificially respired dog. The model represents a severe form of myocardial ischaemia and mimics the clinical situation in which usually more than one coronary artery is involved in the stenotic process. Verapamil (0.15 mg kg -1 i.v.) moderated the extent of the ischaemic changes (indicated by the ST segment elevation in the epicardial and endocardial ECG) as well as their consequences e.g. the incidence and severity of early postocclusion and reperfusion arrhythmias. This beneficial effect was probably due to the drug-induced favourable haemodynamic action (reduction of left ventricular end-diastolic pressure and slight increase in left ventricular dP/dtmax) and to the electrophysiological effects (e.g. decreased inhomogeneity of electrical activation, diminution of extrasystolic activity) and blood flow changes (enhanced blood supply to the ischaemic subepicardium).

AB - The effect of verapamil was studied in a new canine model of local myocardial ischaemia. In this model in addition to the critical constriction of the left circumflex coronary artery, the left anterior descending branch was suddenly occluded. Experiments were performed in the anaesthetized, thoracotomized and artificially respired dog. The model represents a severe form of myocardial ischaemia and mimics the clinical situation in which usually more than one coronary artery is involved in the stenotic process. Verapamil (0.15 mg kg -1 i.v.) moderated the extent of the ischaemic changes (indicated by the ST segment elevation in the epicardial and endocardial ECG) as well as their consequences e.g. the incidence and severity of early postocclusion and reperfusion arrhythmias. This beneficial effect was probably due to the drug-induced favourable haemodynamic action (reduction of left ventricular end-diastolic pressure and slight increase in left ventricular dP/dtmax) and to the electrophysiological effects (e.g. decreased inhomogeneity of electrical activation, diminution of extrasystolic activity) and blood flow changes (enhanced blood supply to the ischaemic subepicardium).

KW - Arrhythmias

KW - Left anterior descending coronary artery occlusion

KW - Left circumflex coronary artery constriction

KW - Myocardial ischaemia

KW - Regional myocardial blood flow

KW - Verapamil

UR - http://www.scopus.com/inward/record.url?scp=0023519574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023519574&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(87)90004-5

DO - 10.1016/0014-2999(87)90004-5

M3 - Article

VL - 144

SP - 15

EP - 27

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -